Sherri Smith
Impact in
-
- Fibroblast Growth Factor Research
- Protein Interaction Studies and Fluorescence Analysis
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
Papers in
-
- Cancer therapeutics and mechanisms 3
- Fibroblast Growth Factor Research 3
- Epigenetics and DNA Methylation 2
-
- Pharmacogenetics and Drug Metabolism 6
- Co-authors
- Nigel J. Waters (8 shared papers)Robert Sullivan (1 shared paper)Yuen Shing (1 shared paper)Shawn M. Davidson (1 shared paper)Joachim Sasse (1 shared paper)John A. Smith (1 shared paper)Michael Klagsbrun (1 shared paper)Michael F. Wilkemeyer (1 shared paper)
- Journals
- Xenobiotica (3 papers)Molecular Cancer Therapeutics (2 papers)European Journal of Cancer (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Sherri Smith
13 papers receiving 317 citations
Peers
Comparison fields: 5 of 83
- Developmental Neuroscience 14
- Molecular Biology 186
- Cell Biology 44
- Pediatrics, Perinatology and Child Health 48
- Pharmacology 19
Countries citing papers authored by Sherri Smith
This map shows the geographic impact of Sherri Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherri Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherri Smith more than expected).
Fields of papers citing papers by Sherri Smith
This network shows the impact of papers produced by Sherri Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherri Smith. The network helps show where Sherri Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherri Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 100 | |
| 2 | 1987 | 100 | |
| 3 | 2000 | 50 | |
| 4 | 2015 | 23 | |
| 5 | 2018 | 14 | |
| 6 | 2018 | 14 | |
| 7 | 2010 | 10 | |
| 8 | 2016 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2020 | 3 | |
| 11 | 2016 | 2 | |
| 12 | 2021 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 0 | |
| 15 | 2015 | 0 | |
| 16 | 2019 | 0 | |
| 17 | 2021 | 0 | |
| 18 | 2019 | 0 |
About Sherri Smith
Sherri Smith is a scholar working on Molecular Biology, Pharmacology, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 18 papers that have together received 329 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Cancer therapeutics and mechanisms (3 papers), Lung Cancer Treatments and Mutations (3 papers), Fibroblast Growth Factor Research (3 papers), Chemical Reactions and Isotopes (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Developmental Neuroscience (14 citations), Molecular Biology (186 citations), Cell Biology (44 citations), Pediatrics, Perinatology and Child Health (48 citations) and Pharmacology (19 citations). Sherri Smith has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Nigel J. Waters, Robert Sullivan, Yuen Shing, Shawn M. Davidson, Joachim Sasse, John A. Smith, Michael Klagsbrun, Michael F. Wilkemeyer, Michael E. Charness and Richard D. E. Burton. Their work appears in journals such as Xenobiotica, Molecular Cancer Therapeutics, European Journal of Cancer, Cancer Chemotherapy and Pharmacology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.